csirt@kutim:~/threat-intel/cve/CVE-2020-14706

Katalog CVE

CVSS 5.9 · Medium EPSS 1,1%

Kerentanan pada oracle primavera p6 enterprise project portfolio management. Skor CVSS 3.1 5.9 (Medium) menurut NVD.

Deskripsi (NVD)

Vulnerability in the Primavera P6 Enterprise Project Portfolio Management product of Oracle Construction and Engineering (component: Web Access). Supported versions that are affected are 17.1.0.0-17.12.17.1, 18.1.0.0-18.8.19 and 19.12.0-19.12.5. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Primavera P6 Enterprise Project Portfolio Management. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Primavera P6 Enterprise Project Portfolio Management accessible data as well as unauthorized update, insert or delete access to some of Primavera P6 Enterprise Project Portfolio Management accessible data. CVSS 3.1 Base Score 5.9 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:L/A:N).

Rincian

Terbit di NVD
15 Juli 2020
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
5.9 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:L/A:N · uraikan di kalkulator
EPSS (30 hari)
1,1% peluang dieksploitasi; lebih tinggi dari 65,6% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
oracle primavera p6 enterprise project portfolio management Versi 17.1.0.0 hingga 17.12.17.1
oracle primavera p6 enterprise project portfolio management Versi 18.1.0.0 hingga 18.8.19.0
oracle primavera p6 enterprise project portfolio management Versi 19.12.0.0 hingga 19.12.5.0

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.